文献速递肝病

肝病女性的辅助生殖技术治疗结局

Assisted Reproductive Technology Treatment Outcomes in Women With Liver Disease.
PubMed 文献 · Am J Gastroenterol · 2023-03-20

这项回顾性研究评估了2002至2021年间在大型生殖中心接受辅助生殖技术(ART)治疗的卵巢储备正常的肝病女性,并与无肝病对照比较。共纳入295例肝病女性(平均年龄37.8±5.2岁),实施1033个ART周期,其中115例实施186个体外受精(IVF)周期。结果显示肝病患者在控制性卵巢刺激反应、胚胎受精率、倍性结局以及单囊胚移植后的临床妊娠、临床妊娠丢失和活产率方面与对照均无统计学显著差异。

要点

  • 肝病女性IVF中控制性卵巢刺激反应、受精率及倍性结局与无肝病者无显著差异
  • 单囊胚移植后临床妊娠、妊娠丢失及活产率在肝病组与对照组间无显著差异
  • 该研究为迄今评估肝病女性IVF疗效的最大样本研究

核心结论

  • 肝病患者的辅助生殖技术治疗结局与无肝病患者相似。

研究设计与样本

  • 回顾性研究,纳入2002至2021年在大型生殖中心接受ART治疗且卵巢储备正常的肝病女性295例(平均年龄37.8±5.2岁,共1033个ART周期,其中115例实施186个IVF周期),并与无肝病对照比较。

主要发现

  • 295例肝病女性中6例(2.0%)肝硬化、8例(2.7%)肝移植后、281例(95.3%)慢性肝病,以病毒性肝炎(乙型和丙型)最常见。
  • 在实施IVF及胚胎活检的亚组中,纤维化-4评分中位数为0.81(0.58-1.03);肝病患者与对照在控制性卵巢刺激反应、胚胎受精率及倍性结局方面无统计学显著差异。
  • 在随后接受单次复苏整倍体胚胎移植以妊娠者中,肝病患者与对照的临床妊娠率、临床妊娠丢失率及活产率无统计学显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There is a need for evidence-based counseling for women with chronic liver disease (LD) who may experience impaired fertility. Currently, the literature on assisted reproductive technology (ART) treatment in women with LD has been limited to a single European case series. We evaluated ART treatment outcomes in patients with LD and compared with controls. METHODS: The retrospective study evaluated women with and without LD who had normal ovarian reserve and underwent ART treatment in a high-volume fertility practice from 2002 to 2021. RESULTS: We identified 295 women with LD (mean age 37.8 ± 5.2 years) who underwent 1,033 ART treatment cycles; of these women, 115 underwent 186 in vitro fertilization (IVF) cycles. Six women (2.0%) had cirrhosis, 8 (2.7%) were postliver transplantation, and 281 (95.3%) had chronic LD, with viral hepatitis (B and C) being the most prevalent. In the subgroup who underwent IVF and embryo biopsy, the median fibrosis-4 score was 0.81 (0.58-1.03), and there were no statistically significant differences in response to controlled ovarian stimulation, embryo fertilization rate, or ploidy outcome in patients with LD compared with controls. In those who subsequently underwent a single thawed euploid embryo transfer to achieve pregnancy, there were no statistically significant differences in rates of clinical pregnancy, clinical pregnancy loss, or live birth in patients with LD compared with controls. DISCUSSION: To the best of our knowledge, this study is the largest to date to evaluate IVF efficacy in women with LD. Our study demonstrates that patients with LD have similar ART treatment outcomes compared with those without LD.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lee JD, Gounko D, Lee JA, et al. Assisted Reproductive Technology Treatment Outcomes in Women With Liver Disease. Am J Gastroenterol. 2023. PMID: 36940434. doi:10.14309/ajg.0000000000002252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。